Accord Adds To Oncology Offering With Orgovyx

Deal For Prostate Cancer Drug Follows Camcevi Leuprolide Launch In US

 
• By David Wallace
  
Prostate cancer words drugs
Accord has struck a deal with Myovant Sciences for prostate cancer drug Orgovyx • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business